Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Cancer Pain × Cognitive Behavioral Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Sleep Initiation and Maintenance Disorders 28 Neoplasms 20 Breast Neoplasms 18 Anxiety Disorders 11 Depression 10 Prostatic Neoplasms 8 Fatigue 8 Motor Activity 4 Lymphoma 4 Lung Neoplasms 4 Weight Loss 3 Melanoma 3 Chronic Pain 3 Smoking Cessation 2 Sleep Wake Disorders 2 Pain 2 Overweight 2 Obesity 2 Nervous System Diseases 2 Multiple Myeloma 2 Lymphoma, Follicular 2 Glioma 2 Glioblastoma 2 Cognitive Dysfunction 2 Carcinoma, Non-Small-Cell Lung 2 Weight Gain 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Stress, Psychological 1 Squamous Cell Carcinoma of Head and Neck 1

Interventions

Morphine 10 Methadone 6 Acetaminophen 5 Oxycodone 4 Lidocaine 4 Fentanyl 4 Ethanol 4 Transcutaneous Electric Nerve Stimulation 3 Buprenorphine 3 Acupuncture Therapy 3 Transcranial Direct Current Stimulation 2 Surveys and Questionnaires 2 Sodium Bicarbonate 2 Radiofrequency Ablation 2 Pharmaceutical Services 2 Ketamine 2 Control Groups 2 Analgesics, Opioid 2 oxycodone naloxone combination 1 nabiximols 1 incobotulinumtoxinA 1 Water 1 Tramadol 1 Therapeutic Touch 1 Telemedicine 1 Tapentadol 1 Sugars 1 Standard of Care 1 Ropivacaine 1 Radiotherapy, Intensity-Modulated 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05774197 2025-11-04

STAMP+CBT

University of Oklahoma

Phase NA Completed

52 enrolled 7 charts

Cancer Pain, Color Vision Defects

Data powered by HemOnc (CC BY 4.0) Colophon ⚡